These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7965658)

  • 1. Evaluation of ultrafiltration for the free-fraction determination of single photon emission computed tomography (SPECT) radiotracers: beta-CIT, IBF, and iomazenil.
    Gandelman MS; Baldwin RM; Zoghbi SS; Zea-Ponce Y; Innis RB
    J Pharm Sci; 1994 Jul; 83(7):1014-9. PubMed ID: 7965658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [SPECT imaging using [123I]beta-CIT and [123I]IBF in extrapyramidal diseases].
    Sasaki T; Amano T; Hashimoto J; Itoh Y; Muramatsu K; Kubo A; Fukuuchi Y
    No To Shinkei; 2003 Jan; 55(1):57-64. PubMed ID: 12649900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters.
    Seibyl JP; Laruelle M; van Dyck CH; Wallace E; Baldwin RM; Zoghbi S; Zea-Ponce Y; Neumeyer JL; Charney DS; Hoffer PB; Innis RB
    J Nucl Med; 1996 Feb; 37(2):222-8. PubMed ID: 8667048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI-based correction for partial-volume effect improves detectability of intractable epileptogenic foci on 123I-iomazenil brain SPECT images.
    Kato H; Shimosegawa E; Oku N; Kitagawa K; Kishima H; Saitoh Y; Kato A; Yoshimine T; Hatazawa J
    J Nucl Med; 2008 Mar; 49(3):383-9. PubMed ID: 18287271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: kinetic and equilibrium paradigms.
    Abi-Dargham A; Laruelle M; Seibyl J; Rattner Z; Baldwin RM; Zoghbi SS; Zea-Ponce Y; Bremner JD; Hyde TM; Charney DS
    J Nucl Med; 1994 Feb; 35(2):228-38. PubMed ID: 8294990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of dopamine transporters and D2 receptors in patients with Parkinson's disease and multiple system atrophy.
    Knudsen GM; Karlsborg M; Thomsen G; Krabbe K; Regeur L; Nygaard T; Videbaek C; Werdelin L
    Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1631-8. PubMed ID: 15583914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of IBF as a D-2 dopamine receptor imaging agent in nonhuman primates.
    Billings JJ; Guo YZ; Kung MP; Kung HF
    Eur J Nucl Med; 1993 Dec; 20(12):1146-53. PubMed ID: 8299649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative estimation of I-123-Iomazenil receptor binding in temporal lobe epilepsies using two SPECT acquisitions--comparison with the regional cerebral blood flow and a compartment model.
    Venz S; Hierholzer J; Cordes M; Straub HB; Keske U; Meencke HJ; Eichstädt H; Felix R
    Nuklearmedizin; 1998 Mar; 37(2):49-56. PubMed ID: 9547750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Baldwin RM; Zoghbi S; Zea-Ponce Y; Charney DS; van Dyck CH; Hoffer PB; Innis RB
    J Nucl Med; 1997 Sep; 38(9):1453-9. PubMed ID: 9293807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproducibility of SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil.
    Abi-Dargham A; Gandelman M; Zoghbi SS; Laruelle M; Baldwin RM; Randall P; Zea-Ponce Y; Charney DS; Hoffer PB; Innis RB
    J Nucl Med; 1995 Feb; 36(2):167-75. PubMed ID: 7830108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of [123I]beta-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity.
    Reneman L; Booij J; Habraken JB; De Bruin K; Hatzidimitriou G; Den Heeten GJ; Ricaurte GA
    Synapse; 2002 Dec; 46(3):199-205. PubMed ID: 12325046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vivo autoradiographic benzodiazepine receptor imaging with 125I-iomazenil (Ro 16-0154)].
    Odano I; Nakajima T; Miyashita K; Takahashi N; Fujita M; Naritomi H; Furusawa T; Hayashi S; Sakai K
    Kaku Igaku; 1993 Jul; 30(7):761-7. PubMed ID: 8397310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT.
    Ichise M; Ballinger JR; Golan H; Vines D; Luong A; Tsai S; Kung HF
    J Nucl Med; 1996 Mar; 37(3):513-20. PubMed ID: 8772658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N.c.a. radiosynthesis of [123,124I]beta-CIT, plasma analysis and pharmacokinetic studies with SPECT and PET.
    Coenen HH; Dutschka K; Müller SP; Geworski L; Farahati J; Reiners C
    Nucl Med Biol; 1995 Nov; 22(8):977-84. PubMed ID: 8998475
    [No Abstract]   [Full Text] [Related]  

  • 15. Brain uptake of iomazenil in cirrhotic patients: a single photon emission tomography study.
    Kapczinski F; Quevedo J; Curran HV; Fleminger S; Toone B; Cluckie A; Lader M
    J Psychopharmacol; 1999; 13(3):219-25. PubMed ID: 10512075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similarity and robustness of PET and SPECT binding parameters for benzodiazepine receptors.
    Millet P; Graf C; Buck A; Walder B; Westera G; Broggini C; Arigoni M; Slosman D; Bouras C; Ibáñez V
    J Cereb Blood Flow Metab; 2000 Nov; 20(11):1587-603. PubMed ID: 11083234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT.
    Abi-Dargham A; Gandelman MS; DeErausquin GA; Zea-Ponce Y; Zoghbi SS; Baldwin RM; Laruelle M; Charney DS; Hoffer PB; Neumeyer JL; Innis RB
    J Nucl Med; 1996 Jul; 37(7):1129-33. PubMed ID: 8965183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maturational Changes of Gamma-Aminobutyric Acid A Receptors Measured With Benzodiazepine Binding of Iodine 123 Iomazenil Single-Photon Emission Computed Tomography.
    Ikemoto S; Hamano SI; Hirata Y; Matsuura R; Kikuchi K
    Pediatr Neurol; 2018 May; 82():19-24. PubMed ID: 29625846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodine-123-IBF SPECT evaluation of extrapyramidal diseases.
    Buck A; Westera G; Sutter M; Albani C; Kung HF; vonSchulthess GK
    J Nucl Med; 1995 Jul; 36(7):1196-200. PubMed ID: 7790944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phase 1 clinical study of 123I-IBF, a new radioligand for evaluating dopamine D2 receptor with SPECT (I); biodistribution and dosimetry].
    Yonekura Y; Sadato N; Tsuchida T; Uematsu H; Nakamura S; Yamamoto K; Ishii Y
    Kaku Igaku; 1999 Feb; 36(2):145-53. PubMed ID: 10213982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.